EXPECT ENDOSCOPIC ULTRASOUND ASPIRATION NEEDLE

K112198 · Boston Scientific Corporation · ODG · Sep 14, 2011 · Gastroenterology, Urology

Device Facts

Record IDK112198
Device NameEXPECT ENDOSCOPIC ULTRASOUND ASPIRATION NEEDLE
ApplicantBoston Scientific Corporation
Product CodeODG · Gastroenterology, Urology
Decision DateSep 14, 2011
DecisionSESE
Submission TypeSpecial
Regulation21 CFR 876.1500
Device ClassClass 2

Intended Use

The Expect™ EUS-FNA device is intended for sampling targeted submucosal and extramural gastrointestinal lesions through the accessory channel of a curvilinear echoendoscope.

Device Story

The Expect™ Endoscopic Ultrasound Aspiration Needle (EUS-FNA) is a manual surgical instrument used by physicians during endoscopic procedures. The device is inserted through the accessory channel of a curvilinear array (CLA) echoendoscope into the digestive tract. The physician targets submucosal or extramural lesions identified via ultrasound imaging. By penetrating the lesion with the needle and applying suction, the device acquires tissue samples for diagnostic analysis. The device facilitates minimally invasive biopsy, potentially reducing the need for more invasive surgical procedures. It is a mechanical device with no electronic or software components.

Clinical Evidence

Bench testing only. No clinical data was required or provided to support this 510(k) notification. Performance was verified through design verification and biocompatibility testing.

Technological Characteristics

The device consists of a nitinol aspiration needle designed for use with a curvilinear array echoendoscope. It utilizes a standard luer connection for coupling to the echoendoscope biopsy channel. The device is a mechanical instrument; it does not utilize electrical energy, software, or algorithms.

Indications for Use

Indicated for sampling targeted submucosal and extramural gastrointestinal lesions in patients requiring endoscopic ultrasound-guided fine needle aspiration.

Regulatory Classification

Identification

An endoscope and accessories is a device used to provide access, illumination, and allow observation or manipulation of body cavities, hollow organs, and canals. The device consists of various rigid or flexible instruments that are inserted into body spaces and may include an optical system for conveying an image to the user's eye and their accessories may assist in gaining access or increase the versatility and augment the capabilities of the devices. Examples of devices that are within this generic type of device include cleaning accessories for endoscopes, photographic accessories for endoscopes, nonpowered anoscopes, binolcular attachments for endoscopes, pocket battery boxes, flexible or rigid choledochoscopes, colonoscopes, diagnostic cystoscopes, cystourethroscopes, enteroscopes, esophagogastroduodenoscopes, rigid esophagoscopes, fiberoptic illuminators for endoscopes, incandescent endoscope lamps, biliary pancreatoscopes, proctoscopes, resectoscopes, nephroscopes, sigmoidoscopes, ureteroscopes, urethroscopes, endomagnetic retrievers, cytology brushes for endoscopes, and lubricating jelly for transurethral surgical instruments. This section does not apply to endoscopes that have specialized uses in other medical specialty areas and that are covered by classification regulations in other parts of the device classification regulations.

Special Controls

*Classification* —(1)*Class II (special controls).* The device, when it is an endoscope disinfectant basin, which consists solely of a container that holds disinfectant and endoscopes and accessories; an endoscopic magnetic retriever intended for single use; sterile scissors for cystoscope intended for single use; a disposable, non-powered endoscopic grasping/cutting instrument intended for single use; a diagnostic incandescent light source; a fiberoptic photographic light source; a routine fiberoptic light source; an endoscopic sponge carrier; a xenon arc endoscope light source; an endoscope transformer; an LED light source; or a gastroenterology-urology endoscopic guidewire, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 876.9.(2) Class I for the photographic accessories for endoscope, miscellaneous bulb adapter for endoscope, binocular attachment for endoscope, eyepiece attachment for prescription lens, teaching attachment, inflation bulb, measuring device for panendoscope, photographic equipment for physiologic function monitor, special lens instrument for endoscope, smoke removal tube, rechargeable battery box, pocket battery box, bite block for endoscope, and cleaning brush for endoscope. The devices subject to this paragraph (b)(2) are exempt from the premarket notification procedures in subpart E of part 807of this chapter, subject to the limitations in § 876.9.

Predicate Devices

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ ## K12198 SEP 1 4 2011 SECTION 6 510(k) SUMMARY ### 510(k) SUMMARY 1. Submitter: Boston Scientific Corporation 100 Boston Scientific Way Marlborough, MA 01752 Telephone: 508-683-4359 Fax: 508-683-5939 Contact: Ashley Pyle Regulatory Affairs Manager Date Prepared: July 29, 2011 ### 2. Proposed Device: Trade Name: Expect 101 Endoscopic Aspiration Needle Classification Name: Endoscope and Accessories & Endoscopic Ultrasound System Regulation Number: 876.1500 & 876.1075 Product Code: FCG and ODG Classification: Class II ### 3. Predicate Device: Trade Name: Expect™ Endoscopic Aspiration Needle Manufacturer and Clearance Number: Boston Scientific Corp. K110030 & K100712 Classification Name: Endoscope and Accessories & Endoscopic Ultrasound System Regulation Number: 876.1500 & 876.1075 Product Code: FCG and ODG Classification: Class II ### 4. Device Description: The Expect™ Endoscopic Ultrasound Aspiration Needle (EUS-FNA) is an endoscopic ultrasound aspiration needle that can be coupled to the biopsy channel of a Curvilinear Array (CLA) Echoendoscope with a standard luer connection and delivered into the digestive tract. The needle is used to acquire aspiration samples from lesions within and adjacent to the digestive system's major lumens that can be identified and targeted using the echoendoscope. An aspiration sample is obtained by penetrating the lesion with the needle while applying suction. ### 5. Indications for Use: The Expect™ EUS-FNA device is intended for sampling targeted submucosal and extramural gastrointestinal lesions through the accessory channel of a curvilinear echoendoscope. Special 510(k) Premarket Notification, Expect Endoscopic Ultrasound Aspiration Needle {1}------------------------------------------------ # K112198 ## 6. Technological Characteristics: The proposed Expect™ EUS-FNA device is a new configuration, which has a needle composed of nitinol. The currently cleared Expect™ EUS-FNA needle is composed of chromium cobalt material (K110030). ## 7. Performance Data: Bench Testing has been performed on the proposed Expect™ EUS-FNA device with nitinol needle component, which demonstrates that the nitinol needle component met the required specifications for the completed design verification and biocompatibility tests. ## 8. Conclusion: Boston Scientific Corporation has demonstrated that the proposed Expect™ Endoscopic Aspiration Needle with the nitionl needle component is substantially equivalent to the currently cleared Expect™ EUS-FNA devices with chromium cobalt needle components (K110030). {2}------------------------------------------------ Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized depiction of an eagle or bird-like figure with three curved lines representing its wings or body. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" is arranged in a circular fashion around the emblem. Food and Drug Administration 10903 New Hampshire Avenue Document Mail Center - WO66-G609 Silver Spring, MD 20993-0002 Ms. Ashley Pyle Regulatory Affairs Manager Boston Scientific Corporation 100 Boston Scientific Way MARLBOROUGH MA 01752 SEP 1 4 2011 Re: K112198 Trade/Device Name: Expect™ Endoscopic Aspiration Needle Regulation Number: 21 CFR\$ 876.1500 Regulation Name: Endoscope and accessories Regulatory Class: II Product Code: ODG, FCG Dated: August 25, 2011 Received: August 26, 2011 Dear Ms. Pyle: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related {3}------------------------------------------------ ## Page 2 adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm. Sincerely yours, Hichard Lemming Herbert P. Lerner, M.D., Director (Acting) Division of Reproductive, Gastro-Renal and Urological Devices Office of Device Evaluation Center for Devices and Radiological Health. Enclosure {4}------------------------------------------------ KII2198 ## SECTION 5 INDICATIONS FOR USE STATEMENT -510(k) Number (if known): --------------------------------------------------------------------------------------------------------------------------------------------------- Device Name: Expect™ Endoscopic Aspiration Needle Indications for Use: The Expect™ Needle is designed to sample targeted submucosal and extramural lesions through the accessory channel of a curvilinear echoendoscope. Prescription Use X (Part 21 CFR 801 Subpart D) AND/OR Over-The-Counter Use (21 CFR 807 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence Concurrence of CDRH, Office of Device Evaluation (ODE) | (Division Sign-Off) | 8 | |----------------------------------------------------------------|---------| | Division of Reproductive, Gastro Renal, and Urological Devices | | | 510(k) Number | K112198 | Special 510(K) Premarket Notification, Expect Endoscopic Ultrasound Aspiration Needle 000015
Innolitics
510(k) Summary
Decision Summary
Classification Order
Enter a record ID and click Load to view the document.
100%